11282-Lymphomas-Non-Hodgkins-524

Lymphomas

(SGN35-015) A phase 2 open-label study of brentuximab vedotin in front-line therapy of Hodgkin lymphoma (HL) and CD30-expressing peripheral T-cell lymphoma (PTCL) in older patients or patients with significant comorbidities ineligible for standard chemotherapy

  • Details

ClinicalTrials.gov ID: NCT01716806
Diagnosis Type: Non-Hodgkins
USOR Number: 11282

  • Address

2800 Highway 75 North
Sherman, TX 75090
P: (903) 868-4700

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.